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Abstract
While major liver resections have become increasingly safe due to better understanding of anatomy and refinement of
operative techniques, liver failure following partial hepatectomy still occurs from time to time and remains incompletely
understood. Observationally, certain high-risk circumstances exist, namely, massive resection with small liver remnants,
preexisting liver disease, and advancing age, where liver failure is more likely to happen. Upon review of available clinical
and experimental studies, an interplay of factors such as impaired regeneration, oxidative stress, preferential triggering of
apoptotic pathways, decreased oxygen availability, heightened energy-dependent metabolic demands, and energy-
consuming inflammatory stimuli work to produce failing hepatocellular functions.
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Background
Among all organs, the liver is unique in its ability to
repair itself after suffering loss of tissue mass from
toxins, infectious agents or surgical resection. This
regenerative capacity has made it possible for sur-
geons to remove large portions of liver without
permanent impairment of function. From the first
descriptions by Keen in 1899 [1] of major hepatic
resections for tumors, the postoperative course of
these patients was largely uneventful, provided that
they survived the operation. Mortality was high
(almost 15% in 74 patients), usually from bleeding,
and few, if any, of the deaths seemed to be due to liver
failure. With a clearer understanding of hepatic
anatomy [2], and refinements in operative technique
[3,4], liver resection became more commonplace.
Foster and Berman [5], in their 1974 liver tumor
survey, examined 621 patients who had undergone
liver resection in 98 different hospitals. The overall
mortality rate was 13%. Upon reviewing the deaths,
the authors found that 29 patients succumbed to
‘‘liver failure’’, most within 30 days of operation.
Fourteen of these deaths were thought to be due to
technical causes, usually removal of ‘‘too much’’ liver
or vascular compromise to remnant liver, and 12
deaths were in patients with cirrhosis. Three cases of
liver failure could not be explained. More recent
clinical series cast a similar light. In a series of over
400 partial hepatectomies, Iwatsuki and Starzl [6]
detailed 19 in-hospital deaths. Eleven of these deaths
were due to liver failure, nine after the first post-
operative week and six after 1 month. In this group of
11 patients, 8 had undergone extended right hepa-
tectomy (trisegmentectomy) and 7 were over 60 years
of age. Savage and Malt [7] published a large series of
hepatectomies, 75% of which were major, in which 12
patients died of liver failure (and five from septicemia)
and 14 developed reversible liver insufficiency. Scheel
and Stangl [8] observed a greater chance of liver
failure in non-cirrhotics (11.5%) if more than 50% of
functioning liver was removed*resulting in 5 (of 18)
deaths*than if less were resected (1.3%). The
dangers of extended hepatic resections, during which
well over half of the liver was removed, were illu-
strated by Melendez and co-authors [9]. They en-
countered 14 postoperative deaths in these patients, 6
from sepsis and 3 from liver failure. Others [10] noted
similar findings, observing that sepsis and liver failure
accounted for five of seven postoperative deaths.
The interplay of clinical factors that predispose to
liver failure following partial hepatectomy is the
subject of this review. We will examine a number of
clinical situations, which might shed light on causes of
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liver failure following resection and delve into experi-
mental data that could help to explain some of the
clinical observations.
Definition
There is no clear definition of liver failure following
partial hepatectomy. In clinical series there is even some
confusion regarding cause of death, whether liver
failure, sepsis, or multi-organ failure, all of which may
have in common progressive liver dysfunction. Of
course, liver failure may be said to occur if, following
partial hepatectomy, a patient dies with deepening
jaundice, worsening coagulopathy, and encephalopa-
thy. One may refer to the definition of ‘‘acute’’ or
‘‘fulminant’’ liver failure as suggested by Hoofnagle
[11] and Bernuau & Benhamou [12] consisting of a
progressive hyperbilirubinemia, derangements of syn-
thetic function manifested by a decrease in hepatic
dependent clotting factors, and appearance of ence-
phalopathy, which lead to death or eventual recovery.
Clinicians often recognize a normalization of the serum
bilirubin for the first few days following partial hepa-
tectomy, but then a steady increase in bilirubin
accompanied by other signs of liver insufficiency. This
may correspond to a failure of the regenerative process,
as peak DNA synthesis occurs at about 7 days in
humans [13]. While there may be an early and transient
increase in total serum bilirubin for the first few days
after partial hepatectomy normally, a sustained and
progressive rise may signal significant dysfunction,
especially when coupled with encephalopathic beha-
vior. Histopathologically, some have classified liver
failure following hepatectomy as two types: cholestatic,
characterized by bile plugging, hepatocyte regenera-
tion, and fibrosis in Disse’s space; and nonregenerative,
characterized by apoptosis of hepatocytes [14]. While
liver failure may be fulminant, with death occurring
within days, often the onset is insidious, and deteriora-
tion of hepatic function extends over weeks before
either proving fatal or improving.
The liver and ischemia
In the usual course of limited inflow occlusion during
partial hepatectomy, it is unlikely that ischemia alone is
sufficient to produce enough hepatocellular injury to
cause dysfunction. The liver is remarkably resistant to
normothermic ischemia. In-flow occlusion, the so-
called Pringle maneuver, has been used to control
parenchymal bleeding for periods of up to 1 hour with
little detectable penalty [15]. In fact, the maneuver is
commonly done for hepatic resections to reduce
bleeding. That some degree of cellular damage occurs
is manifested by modest and transient rises in serum
transaminases but without clinical evidence of dysfunc-
tion. A less common maneuver to control blood loss is
total vascular exclusion (TVE). The first report of
TVE, clamping of in-flow and out-flow (inferior vena
cava or individual hepatic veins), for up to 38 minutes,
was described by Huguet and associates [16] in nine
patients undergoing partial hepatectomy without a
death. Henri Bismuth and colleagues [17] employed
TVE and demonstrated the resiliency of the liver to
normothermic ischemia in 51 patients with occlusive
periods averaging 50 minutes. There was only one
postoperative death in a patient with fatty liver, and no
clinically significant liver dysfunction was reported in
any of the survivors. Huguet and his co-workers [18]
published a follow-up study to their initial work
compiling a series of 59 patients, this time with
ischemic periods exceeding 1 hour with only one death
in a patient who developed portal vein thrombosis and
liver failure. Intra-operative and postoperative biopsies
showed no immediate or long-term derangement of
hepatic architecture by light microscopy. By electron
microscopy, warm ischemic times of approximately 30
minutes produced collapse of sinusoids, focal chroma-
tin condensation at the nuclear margin of hepatocytes,
and mitochondrial and endoplasmic reticulum swel-
ling, but these changes were reversible on reperfusion
[19]. Nevertheless, the liver is not immune to ischemia.
Champion and co-authors [20] studied 19 patients
after prolonged periods of hemorrhagic shock. Hyper-
bilirubinemia was seen 810 days afterwards asso-
ciated with intracellular lipid deposition, periportal cell
necrosis, acute and chronic cellular infiltrate, and bile
plugging. The additional insult of infection caused
maximum hepatic dysfunction, which often led to
multi-system organ failure. Why, in this setting, histo-
pathologic injury was so obvious is not clear unless the
splanchnic response to hypovolemia, with its intense
vasoconstriction, extends beyond the observable per-
iod of shock and produces periods of ischemia well in
excess of the hour ischemic times used in more
controlled surgical situations.
Remnant liver volume
Clinical investigations found that, following removal of
up to 50% of functioning liver, there was usually only a
mild and short-lived increase in serum bilirubin and
depression of serum proteins*both visceral and acute
phase*indicating sustained conservation of hepato-
cellular function [68,2123]. In fact, removal of up to
75% of the liver was tolerated in most patients.
However, it would be advantageous to estimate the
size of the liver remnant after partial hepatectomy to
reduce chances of liver insufficiency. Heymsfield and
colleagues [24] first described volumetric measure-
ments of liver in 1979 using computerized tomography
(CT). In this method serial abdominal transverse cuts
taken at 0.51.0-cm intervals were utilized, the liver
being traced with a cursor, and the segments and
sectors of the liver defined by right, middle, and left
hepatic veins and portal vein bifurcations. The total
liver volume and segmental volumes could then be
calculated in milliliters. This technique was initially
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applied to living donor hepatic transplantation [25],
but Kubota and co-workers [26] investigated its
usefulness in resections of hepatic tumors. The amount
of functioning liver remaining after resection was
expressed as a ratio of remnant to total liver volume.
In a series of 50 patients, resection of up to 5060% of
functional liver was well tolerated in those who had
normal liver function pre-operatively. In further trials,
Shirabe and associates [27] reported a series of 80
patients who had volumetric studies prior to resection.
Liver volume was expressed as ml/m2 body surface
area. There were seven patients who developed liver
failure post-operatively. The mean liver volume in these
seven patients was significantly less (1639/63 vs 3359/
112 ml/m2, p/0.0002), and in those with liver failure
the liver volume was never more than 250 ml/m2.
Others [28] have found major hepatectomies to be
safe with remnant liver volumes at least 25% of pre-
operative values or measured size of approximately
318 cm3 [29]. With the presence of steatosis, 30% or
more of the remnant liver should remain (D. Azoulay,
personal communication).
Reduction in liver size apparently alters hepatic
microcirculation. Kin and colleagues [30] observed a
decrease in portal flow velocity and increase in hepatic
artery resistive index in patients developing liver
dysfunction following partial hepatectomy. Experi-
mentally, creation of a surgical model of acute liver
failure, a 90% hepatectomy in the rat model, pro-
duced an immediate decrease in hepatic microcircu-
latory flow and caused a remarkable increase in
hepatic vascular resistance leading to liver dysfunction
and failure, mirroring clinical findings. This could be
partially reversed by a portal-systemic shunt [31].
From these observations, it appears that a critical
reduction in liver mass leads to sudden portal
hypertension, microcirculatory ischemia, reduced
oxygen delivery, and hepatocellular dysfunction.
Observations in small-for-size liver transplantation
may also shed some light on mechanisms of liver
failure. Clinical experience has shown that the use of
allografts with a graft-to-recipient weight ratio
(GRWR) of B/1% leads to lower graft survival [32].
Experimentally, the use of small allografts has pro-
duced poor outcomes in the swine model [33], with
severe ischemic changes and hyperemia seen histolo-
gically. In the rat model [34], using allografts B/30%
of recipient weight, there was a transient increase in
portal pressure and an increase in hepatic microcir-
culatory blood flow. Again, histologically, there was
sinusoidal congestion and swelling of mitochondria.
Modulation of portal inflow by ligation of the splenic
artery has resulted in lowering of portal and hepatic
arterial flow with good graft survival [35]. Similarly,
creation of a mesocaval type shunt and ligation of the
superior mesenteric artery have improved survival in
swine and resulted in a favorable outcome in one
patient with a GRWRB/1% [36]. It appears, then,
that high portal and hepatic artery flows to small liver
remnants are inherently detrimental and contribute to
alteration of microcirculatory flow, congestion, and
hepatocellular dysfunction.
Other factors may also be at work. Despite an
increase in requirements brought on by surgical stress,
there appears to be a fall in hepatic energy levels over
the first 48 hours following partial hepatectomy
[37,38]. In addition, Bilimoria and others [39] felt
that liver failure after hepatectomy represented a
failure to regenerate at a critical mass of liver tissue.
Eguchi and others [40] showed that expression of
hepatocyte growth factor (HGF) and c-met mRNA in
remnant liver was delayed in a rat model of fulminant
hepatic failure after partial hepatectomy. There was
only a modest increase in weight of the remnant liver
but no signs of regeneration by either BrdU uptake,
proliferating cell nuclear antigen (PCNA), or pre-
sence of mitotic figures. Survivability in a 90%
hepatectomy model has been thought by others [41]
to hinge on the availability of glucose and normal-
ization of blood insulin and glucagon. This may in
part, be due to reconstitution of intracellular adenine
nucleotides and preservation of energy-dependent
functions involved in normal metabolism and new
demands for cellular replication [42].
It is evident that some crucial amount of liver must
remain; yet the precise mechanism for hepatocellular
failure below this critical mass cannot be completely
explained. Very likely, energy supply and demand are
of the essence. Failure of usual metabolic tasks
probably reflects an overwhelmed hepatocyte mass,
which must also deal with the added burden of
regeneration.
Ipsilateral atrophy and compensatory hypertrophy
are recognized occurrences after portal vein ligation.
Therapeutic use of this phenomenon was initially
reported by Makuuchi and co-authors in 1990 [43] in
14 patients with hilar bile duct carcinoma in order to
reduce postoperative morbidity and mortality after
extensive liver resection. Pre-operative portal vein
embolization (PVE) has been shown to increase the
remnant liver size by almost one-third [44]. More
recent clinical studies have shown a benefit from
preoperative PVE in reducing postoperative liver
failure [45], particularly in diseased livers [46].
Additionally, the number of resectable patients has
increased with the use of PVE due to increases in
remnant liver volume [47]. This has proven to be a
useful strategy in reducing the risk of postoperative
liver failure and increasing operability for liver tumors
and, once again, demonstrates the importance of
remnant liver size in postoperative recovery.
Aging
Age likely plays a role in survivability following partial
hepatectomy. Fortner and Lincer [48] noticed a
significant increase in mortality after age 65 (11.1%)
and found a further increase in mortality in this age
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group with extended hepatic resection (30.7%). In the
10 deaths in older patients, 6 were due to liver failure,
and all had normal preoperative liver function.
Similarly, Koperna and colleagues [49] described a
15% death rate in 97 patients over age 65, increasing
to 25% for those over 80 years. In patients developing
postoperative liver failure (n/47) the mortality was
21%. Infectious complications were listed as a fre-
quent postoperative problem. On the other hand, two
Asian studies showed equivalent hospital mortality
and morbidity in aged patients (even over 80 years)
compared to their younger counterparts when resec-
tions were done for hepatocellular carcinoma [50,51],
although in both these reports a minority (31% and
14%) of patients received a major liver resection.
The effect of aging on liver function is unclear. Usual
laboratory values such as hepatic enzyme profiles,
serum albumin, and cholesterol values seem to be
well maintained over a wide age spectrum [52].
However, both basal and taurocholate-stimulated bile
flow and bile acid secretion are decreased in older
experimental animals compared to younger animals
[53], and bile acid synthesis has been shown to decline
in geriatric subjects [54]. There also seems to be a
reduced capacity for acute phase protein synthesis in
older patients after liver resection [55]. Furthermore, it
has been shown that aged livers do not regenerate as
well. Beyer and co-workers [56] established that 1-year-
old rats had retarded restoration of hepatic mass (60
70%) after partial hepatectomy at 1 week compared
with juvenile rats. The induction of thymidylate
synthetase and thymidine kinase, rate-determining
enzymes of DNA synthesis in liver regeneration, are
delayed and maximum activity reduced in 60-week-old
rats after two-thirds hepatectomy [57]. In humans,
smaller allograft liver volumes are found at 1 week
following living donor liver transplantation in donors
over 50 years of age compared with younger patients
[58]. While it is speculative to attribute subtle altera-
tions of liver function and slowing of regeneration to
higher rates of post-hepatectomy liver failure, dimin-
ished hepatic reserve in the elderly may prove critical
after major liver resection. These livers may be more
susceptible to the additive effects of small remnant liver
mass, operative ischemia, or postoperative infection.
Chronic liver disease
The presence of cirrhosis has been associated with a
higher mortality rate after major resection, at times
exceeding 20% [59,60]. This was thought to be due to
compromised liver function from chronic disease
reducing functional liver mass. Indeed, liver failure is
a common cause of death in cirrhotics, often linked to
septic events. Takenaka and colleagues [59] observed
that half of the patients developing post-hepatectomy
liver failure had a preceding infection. Attempts to
quantify preoperative hepatic reserve using the clinical
classification system of ChildPugh [61] have met with
varying success [59,60], and some have advocated a
histologic grading scale, finding that fibrosis was an
independent risk factor for death [62]. Nevertheless, in
the face of cirrhosis, the ChildPugh system of
estimating hepatic reserve continues to be a useful
clinical tool to assess operative risk.
Chronic liver disease has been associated with higher
risk of liver failure following partial hepatectomy.
Cirrhosis and ongoing inflammatory activity have
been cited as contributing factors [59,62,63]. Both
serve to impede healing. An increasingly common form
of liver disease, nonalcoholic fatty liver disease and the
accompanying steatohepatitis, has been found to affect
the risk of major liver resections [64] including post-
operative liver failure. Little and co-authors [65] found
a significantly greater operative mortality in patients
suffering from type I or II diabetes mellitus, the
majority of whom died from postoperative liver failure
and were found to have steatotic changes. It is not clear
why steatotic livers are more susceptible to injury.
Certainly, the presence of steatosis can be detrimental
to graft function both in cadaveric [66] and living donor
[67] liver transplantation. The steatotic liver is more
susceptible to ischemia/reperfusion injury, perhaps due
to an altered sinusoidal microcirculation [68]. There
also appears to be some impairment of hepatic regen-
eration, as demonstrated experimentally in the rat
partial hepatectomy model with a delay seen in the
appearance of regenerative markers such as bromo-
deoxyuridine [69,70].
In an attempt to identify perturbations of liver
function that might lead to postoperative failure,
indocyanine green elimination [71,72], elimination of
hyaluronic acid [73,74], clearance of hepatic 99mTc-
diethylenetriamine pentaacetic acid-galactosyl-human
serum albumin (99mTc-DPTA-GSA) [75], and mea-
surement of hepatic mitochondrial redox state [76]
have been proposed. Das and colleagues [77] found
that the combination of these risk factors predicted
morbidity in 100% of their patients. In the setting of
chronic liver disease, whether cirrhosis and/or chronic
inflammation, damage to the hepatocyte probably
results from regional ischemia (cirrhosis) or liberation
of inflammatory mediators. That regeneration is slo-
wed by the presence of cirrhosis has been shown in
clinical studies using volumetric determinations of
remnant size [21,22]. Slowed regeneration can, in
part, be explained by lower levels of HGF, possibly
due to failure to convert HGF precursor to the
biologically active form [78]. Down-regulation of cell
cycle regulators and impairment of transcription fac-
tors may also play a role [79]. This may be caused by
cirrhosis-induced hypoxia affecting hepatocytes and
associated mesenchymal support cells [80].
Sepsis
Clinically, there appears to be a strong link between
sepsis and post-hepatectomy liver failure. In one series
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of 19 patients developing intraperitoneal septic com-
plications after hepatectomy, 13 died of liver failure
[81]. Experimentally, alteration of gut contents by
antibiotic treatment reduced endotoxemia and mortal-
ity after two-thirds hepatectomy in rats [82]. Admin-
istration of endotoxin following hepatectomy produced
massive hepatic necrosis and 50% mortality, but not in
sham-operated control animals [83], and restricted
liver cell proliferation, perhaps mediated by the cyto-
kine interleukin-1 (IL-1) [84]. Neutralization of en-
dotoxin and blocking of IL-1 reduced hepatic
inflammation and reduced serum levels of transami-
nases in hepatectomized rats [85]. The lethality of
endotoxin in such situations might be explained, in
part, by Kupffer cell dysfunction. Impairment of
Kupffer cell activity has been detected by a reduction
in production of the hepatotrophic cytokine, tumor
necrosis factor-a (TNF-a), which led to retardation of
regeneration [86,87]. Panis and co-authors [88] have
suggested that a critical mass of remaining liver is
dependent not only on the amount of functional
hepatocytes but also on the number of Kupffer cells
available to assist in regeneration through elaboration
of initiator cytokines and clearance of portal vein
endotoxin. The work of Shiratori and others [89] lent
support to this theory by observing that suppression of
Kupffer cells by gadolinium chloride in hepatectomized
rats reduced concentrations of TNF-a and IL-6,
reduced PCNA labeling of hepatocytes, and disturbed
liver regeneration. Impaired clearance of endotoxin in
hepatectomized rats led to multi-organ failure but
could be reversed by the endotoxin-neutralizing N-
terminal bactericidal/permeability-increasing protein
[90]. Furthermore, translocation of enteric bacteria
has been demonstrated in blood, mesenteric lymph
nodes and other organs as early as 2 hours following
90% hepatectomy in rats, reflecting an inability of
surviving Kupffer cells to provide adequate clearance
[91]. In fact, the rate of translocation of intestinal
microflora in portal and arterial blood after 70%
hepatectomy was reported to be 100% at 24 hours
[92]. This translocation was detected in the liver as well
as other intra-abdominal organs. Return of Kupffer cell
function may not normalize for over 2 weeks [93].
However, recovery of Kupffer cell activity has an impact
on outcome in patients in fulminant hepatic failure,
regaining steadily their ability to clear 124I-labeled
microaggregated albumin in those that survived [94].
Reduced Kupffer cell mass and impaired function
coupled with the enhanced permeability and availabil-
ity of enteric microorganisms provides a dangerous
milieu for the production and liberation of endotoxin.
Endotoxin also has a specific effect on the hepato-
cyte. Administration of endotoxin to pigs resulted in
reduced clearance of hepatoiminodiacetic acid (HIDA)
even before increases in cardiac index or decreases in
systemic vascular resistance [95]. Direct contact of
endotoxin with hepatocytes, perhaps through mem-
brane receptors, caused derangements of hepatocyte
function identified as lysosomal damage, decreased
mitochondrial function, and impaired bile salt-inde-
pendent bile flow and sulfobromophthalein excretion
[9698]. In perfused livers of endotoxemic rats,
reduced clearance of bilirubin and taurocholate were
found, reflecting an impairment of intracellular trans-
port rather than altered conjugation [99]. These
changes could be explained by relocation of ATP-
diphosphohydrolases as a result of exposure to endo-
toxin [100]. Others [101] have found a decrease in
synthesis of canalicular multispecific organic anion
transporter protein, perhaps contributing to hyperbi-
lirubinemia and cholestasis. This effect was mediated
by Kupffer cell activation by endotoxin and elaboration
of IL-1 and TNF-a . In addition, bile plugging,
described microscopically in cholestatic liver failure
[14], might be explained by alteration of the tight
junction between hepatocyte couplets, increasing per-
meability and producing bile regurgitation [102].
Endotoxin has been found to impair regeneration by
reducing hepatocyte growth related mRNA and de-
pressing PCNA [76,103].
Endotoxin, then, can play a dual role in post-
hepatectomy liver failure. By action on the Kupffer
cell there is impairment of initiator cytokines neces-
sary for regeneration. This effect is magnified with
reduction in Kupffer cell mass that accompanies
extensive liver resections. At the same time endotoxin
alters the internal milieu of hepatocytes by its effect
on transport mechanisms, initiation of regeneration,
and membrane function. The end result could be a
small liver remnant with defective reticuloendothelial
activity, disrupted hepatocellular metabolism, and
impaired regenerative pathways.
Regeneration
Liver failure can be viewed as a net loss of functioning
hepatocytes to the point that surviving hepatocytes
cannot maintain adequate metabolic functions. This
represents either a failure to regenerate after partial
hepatectomy or accelerated destruction of hepato-
cytes from necrosis or apoptosis. Post-hepatectomy
liver regeneration is a complex, but well orchestrated,
series of events initiated by a number of autocrine,
paracrine, and endocrine hepatotrophic factors [104].
Regeneration has most easily been studied in the rat
or mouse partial hepatectomy model or in cell culture.
These may not be translatable to human liver regen-
eration as events occur much earlier in the rodent
models and cell culture methodology may not take
into account the role of supporting cells, cytokines,
and hepatotrophic factors found in vivo.
Proliferation of all cellular components and matrix
occurs with hepatocytes, the first to begin mitotic
activity. In humans with normal livers, regeneration
occurs in the first 2 weeks after hepatectomy and is
completed by 3 months [21,105,106]. The protoonco-
genes c-fos, c-jun, and c-myc are usually considered the
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markers for the initial phase of regeneration [107].
These genes are expressed even after massive hepatect-
omy in experimental animals [108]. Simultaneously, a
number of genes are expressed in the early phases of
regeneration involved in control of growth [109]. In
response to these molecular events, normally quiescent
and highly differentiated hepatocytes enter and pro-
gress through the various stages of cell replication.
Gene expression is thought to occur after activation by a
number of identifiable hepatotrophic factors. Promi-
nent among these are TNF-a , HGF, epidermal growth
factor (EGF), transforming growth factor-a (TGF)-a ,
and IL-6. It appears that the cytokines TNF-a and IL-6
are early initiators of DNA synthesis in regenerating
hepatocytes, although it is not clear whether their roles
are facultative or triggering [110,111]. Cell cycle
progression requires, in addition to these hepatotrophic
factors, activation of cyclin-dependent kinases (Cdks)
that are regulated by cyclins and Cdks inhibitors [112].
The Cdks inhibitor p21 has been identified as an
important protein in halting liver regeneration and
may be induced by the presence of the hepatocyte
proliferative inhibitor transforming growth factor-b
(TGF-b [113,114]. Regeneration may also be halted
by inhibition of nuclear factor kappa B (NFkB)
[115,116]. NFkB probably prevents apoptosis by
terminating activation of c-Jun NH2-terminal kinase
(JNK) [117].
Part of the initial response of the remnant liver to
partial hepatectomy is induction of members of the
signal transducers and activators of transcription
(Stat). This family of factors participates in the regula-
tion of growth response genes and is induced early
following partial hepatectomy [118]. Experimentally,
in fatty livers, induction of Cdks after partial hepatect-
omy is abolished, alteration of Stat-3 occurs, and
adenosine triphosphate levels are reduced, which
arrests hepatocyte proliferation and impairs regenera-
tion [119]. In fact, others [120] have found hyperin-
duction of Stat-3 after liver injury in obese mice, which
impairs regeneration by up-regulating mechanisms that
impede progression of the cell cycle. Interference in the
regenerative pathways, either by suppression of hepa-
totrophic factors or by up-regulation of cell cycle
inhibitors (or both), may help explain failure of the
remnant liver to sustain metabolic functions.
It is now apparent that nitric oxide (NO) plays an
important role in liver regeneration. Generation of NO
is dependent on cytokine inducible nitric oxide
synthase (iNOS). Levels of iNOS are elevated after
partial hepatectomy in the rat model [121]. In trans-
genic mice with targeted disruption of the iNOS gene,
partial hepatectomy results in heightened caspase-3
activity, hepatocyte apoptosis, and liver failure [122].
One mechanism for the regenerative contribution of
NO may lie in its ability to down-regulate S-adenosyl-
methionine synthesis, which is involved in inhibition of
HGF-induced cyclin D1 and D2 expression [123].
Therefore, any disruption of NO synthesis would seem
to have a deleterious effect on regeneration and may, in
fact, uncover apoptotic pathways.
Apoptosis
Liver cell loss can occur via two mechanisms: necrosis
and apoptosis. Histopathologic studies of failing livers
do not mention necrosis as a prominent finding and, in
fact, observe apoptotic changes in some specimens
[14]. Apoptosis of cells occurs from external or internal
signaling. External signaling involves the cell mem-
brane receptors, TNF-receptor 1 (TNFR1) and the
Fas/Apo receptor. Binding by TNF-a or Fas ligand
activates the caspase cascade, eventually resulting in
cell death. While hepatocytes are rich in these cell
surface receptors, activation usually results in initiation
of regenerative rather than apoptotic pathways
[110,124]. Despite the ability of TNF-a to trigger
apoptotic events by combination with its 55-kDa
TNFR1 and up-regulation of Fas/Apo 1 receptors
[125,126], regenerative pathways seem to prevail even
to the degree of suppressing Fas-signaling apoptotic
cascades [127]. Whether apoptosis plays a significant
role in loss of hepatocytes after partial hepatectomy is
unclear. Lee and co-workers [128] described a three-
fold rise in apoptotic cells at 1 hour following 70%
hepatectomy in rats, and Sakamoto and colleagues
[129] reported a ‘‘wave’’ of apoptosis occurring be-
tween 60 and 96 hours after 70% hepatectomies in
mice. On the other hand experiments in our laboratory
[130] have failed to disclose a meaningful increase in
apoptotic activity following partial hepatectomy in rats
even with endotoxin stimulation and high levels of
TNF-a . It appears difficult, in otherwise intact experi-
mental animals, to induce apoptosis over regeneration
using commonly recognized external stimulators for
‘‘death domain’’ activation in survivable models of
partial hepatectomy.
Internal signaling of the caspase cascade can
occur from oxidative stress focused on the mitochon-
dria. Formation of reactive oxygen species has been
shown to promote apoptosis through creation of
voltage-dependent anion channels in the outer mito-
chondrial membrane [131]. Leakage of cytochrome C
through these channels then induces the entire
caspase cascade, resulting in apoptosis [132]. Addi-
tionally, oxidative stress can cause perturbations of
Ca
2 homeostasis and influx of the cation into the
cytoplasm from outside the cell or the endoplasmic
reticulum, the main intra-cellular store of Ca2.
Influx of Ca2 can cause disruption of mitochondrial
metabolism and alteration of gene transcription lead-
ing to apoptosis [133]. The focus of the anti-apoptotic
proten Bcl-2 and the pro-apoptotic proteins Bax and
Bak may be regulation of Ca2 flux from the
endoplasmic reticulum [134].
Aging can increase susceptibility to oxidative stress.
Ikeyama and associates [135] have shown that hepa-
tocytes from aged rats (2426 months old) exhibited
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reduced proliferative capacity when exposed to hydro-
gen peroxide or epidermal growth factor. These same
investigators subsequently discovered that the proa-
poptotic gene gadd153 is up-regulated in aging rats
and is particularly sensitive to oxidative injury [136].
Aberrant induction can also occur with stimulation by
epidermal growth factor in aging rats. Others [137]
have determined that the calcium-binding protein
senescence marker protein-30 (SMP-30) decreases
with aging. In mutant mice lacking SMP-30, hepato-
cytes were more susceptible to apoptosis induced by
TNF-a . SMP-30 could be considered an anti-apop-
totic protein that, with age and decreasing levels, is
less able to prevent progression of apoptotic events
initiated by external signals.
Summary
Liver failure following partial hepatectomy is more
likely to occur in certain clinical situations. Important
parameters to consider include functional mass of
remnant liver, the age of the patient, and the presence
of pre-existing liver disease such as cirrhosis, chronic
hepatitis, and fatty liver disease. Postoperative infec-
tion can be equally damaging to a regenerating liver.
Each of these conditions interferes with the normal
regenerative pathways and/or initiates apoptotic path-
ways, resulting in a net loss of functional hepatocytes.
The cellular mechanism for liver failure appears may
be the preferential triggering of caspase-dependent
apoptotic pathways, more likely from internal signal-
ing rather than external receptor activation, as well as
down-regulation of the myriad of regenerative factors
involved in moving the resting hepatocyte through
its cell cycle. In particular, the aging process may be
responsible for heightened oxidative stress and sus-
ceptibility to cytochrome release from mitochondria,
in metabolically active hepatocytes after partial hepa-
tectomy, thus providing another pathway for caspase
activation. In the clinical arena attention to factors
that can reduce chances of liver failure following
partial hepatectomy, especially provision of adequate
liver remnant, avoidance of major hepatectomy in the
cirrhotic patient, and caution when embarking on
resections in the steatotic liver, should improve out-
come. It is important for the liver surgeon to
appreciate the effect of sepsis on the remnant liver
and expeditiously address infectious problems that
may occur postoperatively.
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